A team from the Faculty of Medicine and Health Sciences and the Institute of Neurosciences at the University of Barcelona ...
Astellas Gene Therapies remains intent on treating X-linked Myotubular Myopathy (XLMTM) through a gene therapy—but instead of AAV-based resamirigene bilparvovec (AT132), Astellas is now partnering ...
Scribe expects to initiate a first-in-human hypercholesterolemia study in mid-2026 with STX-1150, its lead cardiometabolic assetSTX-1150 is designed to deliver durable therapeutic LDL-C lowering with ...
Scientists identify a "master regulator" that may reset Brain Aging by controlling tau and gene expression in neurons.
The field of cancer epigenetics examines how heritable changes in gene regulation - independent of DNA sequence - impact ...
Explore RNA interference methods, comparing siRNA and shRNA for gene knockdown, their mechanisms, advantages, and ...
The human genome has to be carefully organized so it will fit inside of the nuclei of cells, while also remaining accessible ...
The field of cancer biology has witnessed rapid advances in our understanding of microRNAs (miRNAs) as crucial regulators of ...
A study reveals that kimchi powder activates defenses and regulates inflammation, adjusting the body's immune response.
MicroRNAs, whose discovery was recognized with the 2025 Nobel Prize in Physiology or Medicine, are central regulators of gene ...
Optogenetics has long been a powerful experimental tool, but a growing body of research suggests it may now be approaching a ...
Ocugen, Inc. gene therapy outlook: key 2026 catalysts, Phase 2/3 eye-disease data, BLA plans to 2028, and risks. Click for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback